These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1715601)

  • 1. Tumour marker CA 125 in patients with digestive tract malignancies.
    Haglund C; Kuusela P; Roberts P; Jalanko H
    Scand J Clin Lab Invest; 1991 May; 51(3):265-270. PubMed ID: 1715601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
    Kuusela P; Haglund C; Roberts PJ
    Br J Cancer; 1991 Apr; 63(4):636-40. PubMed ID: 2021550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour markers CA 19-9 and CA 50 in digestive tract malignancies.
    Haglund C; Roberts PJ; Jalanko H; Kuusela P
    Scand J Gastroenterol; 1992; 27(3):169-74. PubMed ID: 1502477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
    Sakamoto K; Haga Y; Yoshimura R; Egami H; Yokoyama Y; Akagi M
    Gut; 1987 Mar; 28(3):323-9. PubMed ID: 3471687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P; Haglund C; Roberts PJ; Jalanko H
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
    Olsson NO; Crimet-Montange D; Martin F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of CA 125 in patients with gastrointestinal cancers.
    Omar YT; al-Naqeeb N; el Nas SA; Awwad AH; Foudeh MO; Safadi NB; Nasralla MY; Ali MA; Szymendera JJ
    Tumour Biol; 1989; 10(6):316-23. PubMed ID: 2480631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sialyl-Tn antigen levels in patients with digestive cancers.
    Motoo Y; Kawakami H; Watanabe H; Satomura Y; Ohta H; Okai T; Makino H; Toya D; Sawabu N
    Oncology; 1991; 48(4):321-6. PubMed ID: 1891175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs].
    Ishii M
    Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer.
    Safi F; Kuhns V; Beger HG
    Int J Biol Markers; 1995; 10(2):100-6. PubMed ID: 7561233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
    Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
    Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
    Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A; Kessler AC
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum levels of CEA and CA 242 in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Kuusela P; Järvinen H; Roberts PJ
    Br J Cancer; 1995 Apr; 71(4):868-72. PubMed ID: 7710956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
    Haglund C; Lundin J; Kuusela P; Roberts PJ
    Br J Cancer; 1994 Sep; 70(3):487-92. PubMed ID: 8080735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies.
    Lopez JB; Royan GP; Lakhwani MN; Mahadaven M; Timor J
    Int J Biol Markers; 1999; 14(3):172-7. PubMed ID: 10569140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new radioimmunoassay detecting early stages of colon cancer: a comparison with CEA, AFP, and Ca 19-9.
    Chester SJ; Maimonis P; Vanzuiden P; Finklestein M; Bookout J; Vezeridis MP
    Dis Markers; 1991; 9(5):265-71. PubMed ID: 1724634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
    Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
    Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.